Rationale Multiple drugs are known to induce metabolic malfunctions, among them second-
generation antipsychotics (SGAs). The pathogenesis of such adverse effects is of …

The atypical antipsychotic olanzapine is often associated with serious metabolic side effects
including weight gain and increased visceral fat. These adverse events are a considerable …

The atypical antipsychotic risperidone (RSP) is often associated with weight gain and
cardiometabolic side effects. The mechanisms for these adverse events are poorly …

Abstract Rationale Atypical antipsychotic drugs (AAPDs) such as olanzapine have a serious
side effect profile including weight gain and metabolic dysfunction, and a number of studies …

Background Atypical antipsychotics, also known as second-generation antipsychotics, are
commonly prescribed as treatment for psychotic disorders in adults, as well as in children …

Atypical antipsychotics (AAPs) are the drug of choice in the management of mental illnesses
by virtue of their advantage over typical antipsychotics ie least tendency of producing …

Olanzapine is an effective antipsychotic drug but since it causes significant weight gain, it is
not well tolerated by psychosis patients. The prebiotic, B-GOS®, attenuates metabolic …

With the emergence of knowledge implicating the human gut microbiome in the
development and regulation of several physiological systems, evidence has accumulated to …

The second-generation antipsychotic olanzapine is effective in reducing psychotic
symptoms but can cause extreme weight gain in human patients. We investigated the role of …

Schizophrenia (SCZ) is a severe mental disorder with high morbidity and lifetime disability
rates. Patients with SCZ have a higher risk of developing metabolic comorbidities such as …